av九九九,亚洲区大香

EU Confirms Vision Risk Tied to Semaglutide EMA EU regulators have confirmed a rare risk of vision loss linked to Novo Nordisk’s semaglutide, used in Wegovy and Ozempic. Drug labels will be updated to reflect the potential for NAION, a serious but very rare eye condition.
$1.09 Billion! Novo Nordisk Expands Production Capacity in Brazil Capacity Novo Nordisk is investing $1.09 billion to expand its Monte Mor facility in Brazil, focusing on Ozempic and Wegovy production. The project will create 500+ jobs by 2028.

Articles Archives

Hot Articles

All Categories

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水